Carcinoma Non Small Cell Lung Clinical Trials

ReadTheTrial indexes 10 studies for Carcinoma Non Small Cell Lung. The most common development stage is Phase 2 (3 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

10 clinical trials found for Carcinoma Non Small Cell Lung.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 3
30%
Phase 1 2
20%
N/A 2
20%
Phase 3 2
20%
Phase 4 1
10%

Trial Status Breakdown

Trials for Carcinoma Non Small Cell Lung

AN OPEN-LABEL PHASE 1 STUDY TO EVALUATE PF-08046037 AS MONOTHERAPY AND PART OF COMBINATION THERAPY IN PARTICIPANTS WITH ADVANCED MALIGNANCIES

NCT06974734 · ACTIVE NOT RECRUITING · Phase 1

Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy in China: A Multicenter, Prospective Cohort Study

NCT06862869 · RECRUITING · N/A

A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

NCT06875310 · RECRUITING · Phase 3

A Phase 3 Randomized Double-blind Study of Adjuvant Pembrolizumab With or Without V940 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy (INTerpath-009)

NCT06623422 · RECRUITING · Phase 3

An Open-label, Single-arm, Multicenter, Prospective Study of Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases

NCT06282874 · ACTIVE NOT RECRUITING · Phase 4

An Open Label, Multicenter, Phase 1/2 Study to Explore the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of TRX-221 in the Treatment of Patients With EGFR Mutant NSCLC Who Progressed Following Prior Therapy With EGFR TKI

NCT06186076 · TERMINATED · Phase 2

A Phase 1/2 Trial (CheckCell-2) in Patients With Metastatic Non-small Cell Lung Cancer (NSCLC) Administering Tumor-Infiltrating Lymphocytes (TILs) in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System

NCT05566223 · WITHDRAWN · Phase 2

A Phase 1 Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632 · RECRUITING · Phase 1

KEYMAKER-U01 Master Study: A Phase 1/2, Umbrella Study With Rolling Arms of Investigational Agents, Pembrolizumab, and Chemotherapy, Alone or in Combination, in Participants With Non-small Cell Lung Cancer (NSCLC)

NCT04165798 · RECRUITING · N/A

A Phase II Study of Osimertinib With On-study and Post-progression Biopsy in the First Line Treatment of EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer

NCT03586453 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Carcinoma Non Small Cell Lung?

There are 10 clinical trials listed for Carcinoma Non Small Cell Lung. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Carcinoma Non Small Cell Lung trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Carcinoma Non Small Cell Lung trials in?

Current Carcinoma Non Small Cell Lung trials are distributed across: Phase 2 (3), Phase 1 (2), N/A (2), Phase 3 (2), Phase 4 (1).

Find More Trials